Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
56,260,480
-
Total 13F shares
-
10,587,998
-
Share change
-
+1,595,780
-
Total reported value
-
$594,413,680
-
Price per share
-
$56.14
-
Number of holders
-
50
-
Value change
-
+$91,848,055
-
Number of buys
-
38
-
Number of sells
-
10
Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) as of Q4 2019
As of 31 Dec 2019 Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 10,587,998 shares of stock of the company.
Largest 10 holders included EPIQ Capital Group, LLC, Capital Research Global Investors, SC US (TTGP), LTD., Capital International Investors, BlackRock Inc., Capital World Investors, VANGUARD GROUP INC, Alphabet Inc., STATE STREET CORP, and NORTHERN TRUST CORP.
This table shows 50 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.